31 March 2021: Lab/In Vitro Research
Connection Between Expression and Hepatocellular Carcinoma Prognosis
Xianfeng Zhang 1A* , Xianjun Zhang 2B* , Xinguo Li 1C* , Hongbing Bao 1D , Guang Li 1E , Ning Li 1F , Hengli Li 1F* , Jian Dou 3G*DOI: 10.12659/MSM.926760
Med Sci Monit 2021; 27:e926760
Table 2 Univariable and multivariate Cox regression analyses for CDC20 in HCC patients.
| Characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95%CI) | P-value | HR (95%CI) | P-value | |
| 2.464 (1.245–4.876) | 0.010* | 2.354 (1.177–4.709) | 0.016* | |
| Age | 0.670 (0.369–1.219) | 0.190 | – | – |
| Sex | 0.834 (0.460–1.512) | 0.550 | – | – |
| Tumor size | 0.863 (0.474–1.573) | 0.631 | – | – |
| Differentiation | 1.930 (1.007–3.700) | 0.048* | – | – |
| TNM stage | 1.304 (0.689–2.469) | 0.415 | – | – |
| Lymphatic metastasis | 1.944 (1.049–3.602) | 0.035* | ||
| HCC – hepatocellular carcinoma; HR – hazard ratio; CI – confidence interval; TNM – tumor node metastasis. * Statistically significant. | ||||